Eva C.  Guinan , MD

Boston Magazine Top Doctors 2011 , December 2011

Boston Magazine

Richardson PG, Soiffer RJ, Antin JH, Uno H, Jin Z, Kurtzberg J, Martin PL, Steinbach G, Murray KF, Vogelsang GB, Chen AR, Krishnan A, Kernan NA, Avigan DE, Spitzer TR, Shulman HM, Di Salvo DN, Revta C, Warren D, Momtaz P, Bradwin G, Wei LJ, Iacobelli M, McDonald GB, Guinan EC. Defibrotide for the treatment of severe hepatic veno-occlusive disease and multi-organ failure post stem cell transplantation: a multi-center, randomized, dose-finding trial. Biol Blood Marrow Transplant (in press)

Davies JK, Gribben JG, Brennan LL, Yuk D, Nadler LM, Guinan EC. Outcome of alloanergized haploidentical bone marrow transplantation after ex vivo costimulatory blockade: results of two phase I studies. Blood 2008; 112(6): 2232-41

Davies JK, Nadler LM, Guinan EC. Expansion of allospecific regulatory T cells after anergized mismatched bone marrow transplantation. Sci Transl Med 2009; 1(1): 1ra3.

Research site for Eva Guinan, MD

Bone Marrow Transplantation and Complications, Growth Factor Therapy, Bone Marrow Failure Syndromes

• Transplantation of anergic histoincompatible bone marrow (N Engl J Med 340:1704, 1999)
• Hematopoietic growth factors trials in pediatric bone marrow failure syndromes (Br J Haematol 103:304, 1998)· Neutrophil defense in BMT patients (Transplantation 73:1522, 2002; Pediatr Infect Dis J 22: 978, 2003)
• Metabolism and energy expenditure after BMT (Am J Clin Nutr 78:104, 2003)
• T cell memory after BMT (Blood 106: 1749, 2005

Children's Hospital Boston